Philadelphia, May 15, 2019 - Inflammation reduces the brain's response to rewards in women, but not in men, according to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier. Reduced activity in the brain's reward center is the signature of anhedonia, a core feature of depression that reflects a loss of enjoyment in things or activities. Women are two-to-three times more likely to be diagnosed with depression, and the new findings pinpoint a key difference in men and women that could contribute to the lopsided rates of the disorder.
"Our study is the first to show that there are sex differences in neural sensitivity to reward in response to inflammation, which has important implications," said senior author Naomi Eisenberger, PhD, University of California, Los Angeles. "This may suggest one reason women experience depression at a far greater rate than men, particularly for the kinds of depression that may be inflammatory in nature."
In the study, healthy men and women received a substance to increase inflammation. Dr. Eisenberger and colleagues measured activity in the reward region of the brain, the ventral striatum, while the participants played a game to receive a monetary reward. Women with greater inflammatory responses showed less brain response in anticipation of potential rewards, but the relationship was not present in men.
"This suggests that women with chronic inflammatory disorders may be particularly vulnerable to developing depression through decreases in sensitivity to reward. Clinicians who treat female patients with inflammatory disorders may want to pay close attention to these patients for possible onset of depressive symptoms," said first author Mona Moieni, PhD, a postdoctoral researcher in the laboratory of Dr. Eisenberger.
"This study highlights the important gender differences that exist in the human brain and suggests a mechanism that might help explain the greater prevalence of depression in women compared to men," said Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Because the increased inflammation had no effect on how men's brains responded to reward, inflammation-induced anhedonia may be an important contributor to the increased rates of depression in women.
###
Notes for editors
The article is "Sex differences in the relationship between inflammation and reward sensitivity: A randomized controlled trial of endotoxin," by Mona Moieni, Kevin Tan, Tristen Inagaki, Keely Muscatell, Janine Dutcher, Ivana Jevtic, Elizabeth Breen, Michael Irwin, and Naomi Eisenberger (https://doi.org/10.1016/j.bpsc.2019.03.010). It appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier.
Copies of this paper are available to credentialed journalists upon request; please contact Rhiannon Bugno at BPCNNI@sobp.org">BPCNNI@sobp.org or +1 214 648 0880. Journalists wishing to interview the authors may contact Naomi Eisenberger, PhD, at neisenbe@ucla.edu">neisenbe@ucla.edu or +1 310 267 5196.
The authors' affiliations and disclosures of financial and conflicts of interests are available in the article.
Cameron S. Carter, MD, is Professor of Psychiatry and Psychology and Director of the Center for Neuroscience at the University of California, Davis. His disclosures of financial and conflicts of interests are available here.
About Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is an official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches. http://www.sobp.org/bpcnni
About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com
Media contact
Rhiannon Bugno, Editorial Office
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
+1 214 648 0880
BPCNNI@sobp.org